Table 1.
Participant Demographics
| n (%) | |
|---|---|
| Study site | |
| Princess Margaret | 65 (85.5%) |
| Sunnybrook | 11 (14.5%) |
| Age at diagnosis | |
| Mean (SD) | 62.0 (10.7) |
| Minimum, Maximum | 38, 84 |
| Ovarian cancer stage | |
| I/II | 9 (11.8%) |
| III/IV | 67 (88.2%) |
| Primary treatment | |
| Neoadjuvant chemotherapy | 33 (43.4%) |
| Primary surgery | 43 (56.6%) |
| Personal history breast cancer | |
| Yes | 6 (7.9%) |
| No | 70 (92.1%) |
| Family history breast or ovarian Cancer | |
| Yes | 34 (44.7%) |
| No | 42 (55.3%) |
| Previous genetic testing in the family | |
| Yes | 11 (14.7%) |
| No | 64 (85.3%) |
| Pre-test counselling prior to survey | |
| Yes | 31 (40.8%) |
| No | 45 (59.2%) |
| Tumour genetic test result | |
| Positive (BRCA1/2 pathogenic variant identified) | 23 (30.3%) |
| Negative | 53 (69.7%) |
| Relationship Status | |
| Partnered | 43 (57.3%) |
| Not partnered | 32 (42.7%) |
| Missing | 1 |
| Children | |
| Children | 43 (56.6%) |
| No children | 33 (43.4%) |
| Education and training | |
| Postsecondary education/training | 61 (82.4%) |
| Secondary school or less | 13 (17.6%) |
| Missing | 2 |
| Household income | |
| 75 K or greater | 24 (50.0%) |
| Less than 75 K | 24 (50.0%) |
| Missing | 28 |
| Race/Ethnicity | |
| White | 52 (71.2%) |
| Other | 21 (28.8%) |
| Missing | 3 |
Demographic information for the entire study cohort (n = 76)